Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026)
Sintx Technologies (SINT) recorded quarterly Cash from Investing Activities of -$7000.0 in Q1 2026, up 83.33% quarter-over-quarter from -$42000.0 in Q4 2025, and up 88.89% on a YoY basis from -$3705.9 in Q1 2025.
Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$7000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 88.89% year-over-year to -$7000.0; the TTM figure through Mar 2026 stood at $969000.0 (up 1253.57% YoY), while the FY2025 annual figure was $913000.0, up 570.62% from the prior year.
- Cash from Investing Activities was -$7000.0 for Q1 2026 at Sintx Technologies, up from -$42000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $666000.0 in Q3 2025 to a low of -$510000.0 in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$55625.0 across 5 years, with a median of -$64000.0 in 2022.
- Biggest YoY gain for Cash from Investing Activities was 2248.39% in 2025; the steepest drop was 520.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$296000.0 in 2022, then surged by 79.05% to -$62000.0 in 2023, then jumped by 116.13% to $10000.0 in 2024, then sank by 520.0% to -$42000.0 in 2025, then soared by 83.33% to -$7000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$7000.0 (Q1 2026), -$42000.0 (Q4 2025), and $666000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Sintx Technologies | 8.79 Mn | 6.90 Mn | 144,000.00 | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | 666,000.00 |
| Sep 30, 2025 | 666,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Sep 30, 2023 | -105,000.00 |